Filing Details

Accession Number:
0001140361-15-023539
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-06-08 18:09:58
Reporting Period:
2015-06-04
Filing Date:
2015-06-08
Accepted Time:
2015-06-08 18:09:58
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1048477 Biomarin Pharmaceutical Inc BMRN Pharmaceutical Preparations (2834) 680397820
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1238403 K Daniel Spiegelman C/O Biomarin Pharmaceutical Inc.,
770 Lindaro St.
San Rafael CA 94901
Evp, Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2015-06-04 1,801 $120.46 29,878 No 4 F Direct
Common Stock Disposition 2015-06-05 1,649 $122.30 28,229 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 F Direct
No 4 S Direct
Footnotes
  1. Trade made pursuant to a 10b5-1 plan executed on March 11, 2015.
  2. The price in column 4 is a weighted average price. The price actually received ranged from $120.25 to $123.86. The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price.